Ophthalmology Doctors in Virgin Island Medicare Details, Address, Contact
5 Ophthalmology doctors found. Showing 1 - 5
 Alfred Lee Anduze, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4500 Sunny Isle Island Medical Center, Chrisitansted, VI 00820 Phone: 340-773-2015 Fax: 340-719-9590 |
Dr. Joseph Anthony Capriotti, MD OPHTHALMOLOGIST Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 4500 Sion Farm, Island Medical Center Suite 19, Christiansted, VI 00820 Phone: 340-773-2015 Fax: 340-719-9590 |
Dr. Kevin Phillip Stewart, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4500 Sion Farm, Island Medical Center Suite 19, Christiansted, VI 00820 Phone: 340-773-2015 Fax: 340-719-9590 |
Dr. Byron W. Biscoe, MD Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 8000 Nisky Shopping Ctr Ste 19-b, St Thomas, VI 00802 Phone: 340-774-3003 Fax: 866-896-5634 |
Dr. Kidane H. Assefa, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: The Eye Clinic, St. Thomas, VI 00803 Phone: 340-774-1531 Fax: 340-774-3704 |
News Archive
Quest PharmaTech to develop, market anti-PSA IgE technology for cancer treatment
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has recently signed an exclusive license agreement with University of California at Los Angeles to develop and market anti-PSA IgE technology for the treatment of cancer.
The aging brain and decision making
The human brain's ability to process information declines with age, but knowledge about the world through experiences tends to rise over time.
NIH awards $30 million to accelerate progress in TB vaccine development
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded $30 million in first-year funding to establish new centers for immunology research to accelerate progress in tuberculosis vaccine development.
EUSA announces publication of PROSTASCINT imaging for prostate cancer in official journal of American Society
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, announced today the publication of 10-year outcome data showing that PROSTASCINT (capromab pendetide) fusion imaging is an effective tool for targeting and guiding the dosing of prostate cancer radiotherapy.
New drug delivery system delivers anticancer drugs that reduce tumor size
Cancer tissue cells are divided into two major groups: cancer cells and cancer stem cells. CSCs are related to cancer progression and dissemination, so it's necessary to eradicate CSCs in order to cure cancer.
› Verified 5 days ago